Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
4.080
-0.190 (-4.45%)
At close: Dec 5, 2025, 4:00 PM EST
4.070
-0.010 (-0.25%)
After-hours: Dec 5, 2025, 4:00 PM EST
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $14.9 million as of December 5, 2025. Its market cap has decreased by -24.86% in one year.
Market Cap
14.90M
Enterprise Value
10.11M
1-Year Change
-24.86%
Ranking
Category
Stock Price
$4.08
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $14.90M, a decrease of -91.02%. That is a compound annual growth rate of -20.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 14.90M | -41.55% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | 40.94M | 138.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |